Very much so skronkman, select few of us found this gem in the low 20's and have been rewarded ever since.
Two key notes from this update -
1. As suspected, 513g delayed due to COVID.
2. CPT Code pending peer review of the clinical utility study from Boston Health.
Good to see more emphasis put on LDT roll out as a near term target while we wait for IVD FDA approvals.
Negatives: No mention of Endometriosis & no sales from Italy rollout either.
Enjoy the weekend folks!
Ann: June 2021 Quarterly Activities Report and Appendix 4C, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $60.56M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 38.0¢ | 36.0¢ | $27.48K | 74.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3100 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 40982 | 2 |
View Market Depth
| Last trade - 13.55pm 07/08/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |